Global Ganja Report

After a one-year hiatus for just the second time since 1973 (the other being the pandemic year of 2020), New York City's Cannabis Parade returned to Lower Manhattan on May 3. The event had become increasingly mainstream in recent years, even drawing big-name politicians—like Sen. Chuck Schumer in 2021 and '22. The next year, the NYC Department of Small Business Services' new cannabis office issued a statement marking the event's 50th anniversary, and paying homage to its Yippie founders! The year after that, 2024, the City became an official partner in the event. But in 2025, the City would not grant a permit for either Washington Square Park or Union Square, the two traditional locations, and instead held a more commercialized NYC Cannabis Festival & Resource Fair outside the Harlem State Office Building on 125th Street. This year, however, downtown activists succeeded in getting a permit for a rally in Washington Square and march to Union Square, where a concert was held featuring the punk-reggae-hip-hop fusion bands Ricanstruction and Rebelmatic. The adversarial spirit, in spite of New York's legalization, brought the event back to its radical roots.

President Donlad Trump on April 18 signed an executive order calling on the DEA and FDA to open legal pathways for research into the therapeutic benefits of certain Schedule I psychedelic drugs—prominently including ibogaine, with an emphasis on its potential to treat PTSD in military veterans. The order instructs the FDA to collaborate with the Department of Veterans Affairs and the private sector "to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies." 

In a paradox, New York authorities are finally unleashing the long-anticipated crackdown on the state’s legion and proliferating unlicensed cannabis retailers—while the licensing program continues to be slowed by obstacles, including legal challenges.

Further adventures of Peter Gorman are chronicled in this quasi-memoir, Magic Mushrooms in India & Other Fantastic Tales. Gorman's best known for his work in the Peruvian Amazon, where he's spent the good part of the last three decades hunting for rare flora and connecting with curanderos who turned him on to ayahuasca and other exotic hallucinogens.

Gorman was a contributing editor at High Times in the '90s, where many of these stories first appeared—visits to India seeking mushrooms and bhang, and to Morocco on the kif trail.

A new study by the Psychedelic Research Group at Imperial College London has reached astonishing findings about the therapeutic potentialities of psilocybin, the psychoactive chemical in magic mushrooms. A first report from the group's study, released in October, indicated that psilocybin can "reset" the brains of depressed patients. A second report, just published in the Journal of Psychopharmacology, indicates that the psychedelic agent may even affect political views.

Did you ever want to trip out for the benefit of science? That's what a lucky group of religious clerics got to do, and researchers are now in the process of evaluating the results. Scientists at Johns Hopkins University in Baltimore signed up more than 20 spiritual leaders from various denominations after issuing a call for volunteers last year. Following an initial screening process, the participants were given strong doses of psilocybin—the psychoactive chemical in magic mushroom.